ZnO Nanowire Arrays on 3D Hierachical Graphene Foam: Biomarker Detection of Parkinson’s Disease
Citations Over TimeTop 1% of 2014 papers
Abstract
We report that vertically aligned ZnO nanowire arrays (ZnO NWAs) were fabricated on 3D graphene foam (GF) and used to selectively detect uric acid (UA), dopamine (DA), and ascorbic acid (AA) by a differential pulse voltammetry method. The optimized ZnO NWA/GF electrode provided a high surface area and high selectivity with a detection limit of 1 nM for UA and DA. The high selectivity in the oxidation potential was explained by the gap difference between the lowest unoccupied and highest occupied molecular orbitals of a biomolecule for a set of given electrodes. This method was further used to detect UA levels in the serum of patients with Parkinson's disease (PD). The UA level was 25% lower in PD patients than in healthy individuals. This finding strongly implies that UA can be used as a biomarker for PD.
Related Papers
- → The effect of substrates on the Raman spectrum of graphene: Graphene- on-sapphire and graphene-on-glass(2007)250 cited
- → Orthotropic friction at the edges and interior of graphene and graphene fluoride and frictional anisotropy of graphene at the nanoscale(2021)1 cited
- A natural advantage? Using mined graphite to make graphene(2013)
- Synthesis and Characterisation of Graphene Single Sheets(2012)
- Unique synthesis of graphene-based materials for clean energy and biological sensing applications(2012)